Exponent (EXPO) to Release Quarterly Earnings on Thursday

Exponent (NASDAQ:EXPO - Get Free Report) is projected to announce its earnings results after the market closes on Thursday, February 6th. Analysts expect the company to announce earnings of $0.40 per share and revenue of $119.60 million for the quarter. Individual that wish to listen to the company's earnings conference call can do so using this link.

Exponent Price Performance

EXPO stock traded up $1.01 during trading on Thursday, hitting $92.27. 74,479 shares of the stock traded hands, compared to its average volume of 193,125. The stock has a market cap of $4.68 billion, a price-to-earnings ratio of 44.77 and a beta of 0.71. Exponent has a 1 year low of $68.70 and a 1 year high of $115.75. The firm's 50 day moving average is $92.93 and its two-hundred day moving average is $101.33.

Insider Activity at Exponent

In other news, Director Carol Lindstrom sold 1,039 shares of the firm's stock in a transaction dated Monday, November 4th. The shares were sold at an average price of $96.32, for a total transaction of $100,076.48. Following the sale, the director now owns 5,871 shares of the company's stock, valued at $565,494.72. This trade represents a 15.04 % decrease in their position. The sale was disclosed in a legal filing with the SEC, which is available through this link. Also, Director Paul R. Johnston sold 1,300 shares of the business's stock in a transaction that occurred on Wednesday, November 20th. The shares were sold at an average price of $95.03, for a total transaction of $123,539.00. Following the transaction, the director now directly owns 59,406 shares of the company's stock, valued at $5,645,352.18. The trade was a 2.14 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold 30,339 shares of company stock valued at $3,103,065 over the last 90 days. Corporate insiders own 2.10% of the company's stock.

About Exponent

Exponent, Inc, together with its subsidiaries, operates as a science and engineering consulting company in the United States and internationally. The company operates in two segments, Engineering and Other Scientific, and Environmental and Health. The Engineering and Other Scientific segment provides services in the areas of biomechanics, biomedical engineering and sciences, buildings and structures, civil engineering, construction consulting, data sciences, electrical engineering and computer science, human factors, materials and corrosion engineering, mechanical engineering, polymer science and materials chemistry, thermal sciences, and vehicle engineering.